Quantitative and qualitative HPLC analysis of thermogenic weight loss products

Pharmazie

Volumn 59, Issue 11, 2004, Pages 819-823

  Schaneberg, B T ^a   Khan, I A ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; CAFFEINE; EPHEDRINE; FORSKOLIN; ICARIIN; PHENYLEPHRINE; PSEUDOEPHEDRINE; REDUCING AGENT; WATER; YOHIMBINE;

ARTICLE; CALIBRATION; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG FORMULATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THERMOGENESIS; ULTRAVIOLET RADIATION;

ANTI-OBESITY AGENTS; BODY TEMPERATURE REGULATION; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, NON-PRESCRIPTION; PLANTS, MEDICINAL; POWDERS; REFERENCE STANDARDS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 8744238294     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dubey MP, Srimal RC, Nityanand S, Dhawan BN (1981) Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J Ethnopharmacol 3: 1-13.
2. Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159: 433-436.
3. Fouad-Tarazi FM, Okabe M, Goren H (1995) Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 99: 604-610.
4. Gurley BJ, Wang P, Gardner SF (1998) Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (mahuang) as determined by high performance liquid chromatography. J Pharm Sci 87: 1547-1553.
5. Jonderko K, Kucio C (1991) Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. Aliment Pharmacol Ther 5: 413-418.
6. Liang HR, Vuorela P, Vuorela H, Hiltunen R (1997) Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense. Planta Med 63: 316-319.
7. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas J-P, Coge F, Galizzi J-P, Boutin JA, Rivet J-M, Dekeyne A, Gobert A (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35: 79-95.
8. Seamon KB, Daly JW (1981) Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cycl Nucl Res 7: 201-224.
9. Sung BH, Lovallo WR, Whitsett T, Wilson MF (1995) Caffeine elevates blood pressure response to exercise in mild hypertensive men. Am J Hypertension 8: 1184-1188.
10. Verwaerde P, Tran MA, Montastruc JL, Senard JM (1997) Effects of yohimbine, an α2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Fundament Clin Pharmacol 11: 567-575.
11. Wahrenberg H, Arner P, Adamsson U, Lins PE, Juhlin-Dannfelt A, Oestman J (1990) Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy. J Intern Med 227 (5): 309-316.
12. Walker RB, Dholakia VN, Brasfield KL, Bakhtiar R (1998) Effect of hydroxypropyl-β-cyclodextrin on the central stimulant activity of (-)-ephedrine and an oxazolidine prodrug in rats. Gen Pharmacol 30: 725-731.
13. Wong S, Mok W, Phaneuf S, Katz S, Salari H (1993) Forskolin inhibits platelet-activating factor binding to platelet receptors independently of adenylyl cyclase activation. Eur J Pharmacol 245(1): 55-61.
14. Wu H, Lien EJ, Lien LL (2003) Chemical and pharmacological investigations of Epimedium species: a survey. Progress in Drug Research 60: 1-57.